Boston Scientific has recalled an agent used to block blood flow to specific vessels due to a safety problem that has been tied to seven injuries and two deaths, the Food and Drug Administration said ...

Anne Wojcicki wants to buy all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, proudly announces the appointment of Dr. Deepak “Dee” Khuntia, M.D., FASTRO, to its esteemed Board ...

Under the agreement, the FDA will use rare powers to require repairs, replacements or refunds for recalled respiratory machines.

Soulaire marketed its external counterpulsation system to grow new arteries, repair organ dysfunction and treat COVID-19, among other uses, without evidence.

Orasure believes it has contained the incident and “preserved the integrity of its core financial and operational systems.” ...

Positive data for Lilly’s medicine tirzepatide in sleep apnea are the latest signal the benefits of GLP-1 agonists could extend beyond diabetes and weight loss.

After Johnson & Johnson has doled out more than $30 billion for Abiomed, Laminar and Shockwave Medical, are more medtech deals on the way?

CEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the recently approved Triclip valve a “billion-dollar opportunity." ...

Biological material can build up and obstruct blood flow in heart failure patients supported by the left ventricular assist devices, the FDA said.

GE Healthcare imaging CEO Jan Makela will resign on July 8 to join another company. Makela has not disclosed which company he will join, but it is a private firm that is not a competitor, according to ...